Skip to main content
TipRanks
Go Ultimate75% OFF
Valink Therapeutics logo

Valink Therapeutics: Valuation, Funding & Investors

Cambridge, Massachusetts 02142, UShttps://www.valinktx.com/Therapeutics

Valink Therapeutics Inc. is a biotechnology company developing first-in-class bispecific antibody-drug conjugates (bsADCs) and other modalities for improved patient outcomes. Valink’s proprietary discovery platform and V-gate™ approach address key challenges of current technologies by expanding the toolbox of available approaches for bispecific antibody therapeutics and bispecific ADCs, unlocking fine-tuned target control, functional outcomes, and improved therapeutic index.

Leadership & Board

Current Number of Employees
30
Current LinkedIn Followers
3,883

Latest Estimated Valuation

Total Amount Raised
$12M
Total Funding Rounds
1
Latest Funding Amount
$12M
Latest Funding Round
Series A

Employee Trend

Valink Therapeutics had 30 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.

30Latest Employee Count
0(0.00%)Week-Over-Week Change
010203040Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Valink Therapeutics had 3,883 followers as of November 9, 2026. The number of followers increased by 5 (0.13%) week-over-week.

3,883Latest Followers Count
5(0.13%)Week-Over-Week Change
01,0002,0003,0004,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 20, 2025Series A$11.80M―

Investors

Investor NameFunding Round
Oxford Science EnterprisesSeries A
RV InvestSeries A
redalpineSeries A
Hoxton VenturesSeries A
LongeVCSeries A
p53 InvestSeries A

Similar Companies

A snapshot of private companies similar to Valink Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis